Wire · opportunities
Abbott Launches SimpleScreen CRC Blood Test for Colorectal Cancer Screening
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 1 October 2026 · Fusion42 review
Abbott has launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test for average-risk adults aged 45 and older in the US, covered by Medicare for eligible beneficiaries. The test offers a new screening option for individuals who decline or fail to complete stool-based or visual screening, aiming to increase screening rates among the 60 million unscreened individuals.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 4 sources have reported it between 30 Sep 2026 and 2 Oct 2026.
◆ ◆ The Wire takeaway
You have a new way to reach patients avoiding stool tests or colonoscopies with Abbott's blood test now Medicare-covered, opening a less invasive path to screening that can boost patient uptake. This shifts how you navigate patient options and reimbursement to accelerate adoption.
◆ Coverage
4 sources · first reported 30 Sep 2026 · latest 2 Oct 2026
◆ Related on Wire
◆ Topics